![Oliver von Stein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Oliver von Stein
Director Ejecutivo en
Berlin Cures Holding AG
.
Perfil
Oliver von Stein currently works at Berlin Cures Holding AG, as Chief Executive Officer & Director from 2024 and Berlin Cures GmbH, as Chief Executive Officer.
Dr. von Stein also formerly worked at Silence Therapeutics Plc, as Operations Director from 2014 to 2015, MediGene AG, as Project Leader, and Flerie AB, as Chief Scientific Officer.
Dr. von Stein received his doctorate degree from Karlsruher Institut für Technologie.
Cargos activos de Oliver von Stein
| Empresas | Cargo | Inicio |
|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Director Ejecutivo | 15/06/2023 |
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Director Ejecutivo | - |
Antiguos cargos conocidos de Oliver von Stein.
| Empresas | Cargo | Fin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Director de Operaciones | 01/08/2015 |
| MEDIGENE AG | Corporate Officer/Principal | - |
| FLERIE INVEST AB | Director Técnico/Científico/I+D | - |
Formación de Oliver von Stein.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
7
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Karlsruher Institut für Technologie
 Karlsruher Institut für Technologie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlin Cures GmbH
Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Health Technology |
- Bolsa de valores
- Insiders
- Oliver von Stein
